Startup · United States

Glyphic Biotechnologies

HQ BerkeleyFounded 202111-50 employees

Glyphic Biotechnologies is a biotechnology company based in Berkeley, California, pioneering next-generation protein sequencing technology. Their core innovation, Protein Sequencing by Expansion (ProSE™), enables massively parallel, single-molecule proteome sequencing with the ability to accurately discriminate all 20 amino acids and post-translational modifications. This breakthrough platform is designed to provide unprecedented precision, scalability, and accessibility in proteomics, aiming to unlock deeper biological insights and accelerate the development of critical new therapies. Founded in 2021, Glyphic is recognized for its strong intellectual property portfolio and its mission to fundamentally rewrite the rules of proteomics, positioning protein sequencing as a defining technology of the 21st century.

Series A · Sep 30, 2025

Every award since FY2008

Federal Prime Contracts$250K obligated · FY2024–FY2024

Explore in Awards →

Obligated: $250K; FY2024–FY2024
Contract actions: 1; 1 awards
Peak year: FY2024; $250K
Top buyer: Defense Health Agency; 100% of obligations

Top buyers

Defense Health Agency$250K 100%

What they sell (PSC)

Health R&D Services; Health Care Services; Basic Research$250K 100%

Industry (NAICS)

Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology)$250K 100%

Where the work is done

New York$250K 100%

Contract pricing

Firm Fixed Price$250K 100%

Competition

Full and Open Competition After Exclusion of Sources$250K 100%

Largest awards1

Medical R and D Purchase Order for A Dha Sttr Phase I, Proposal No. H23C-001-0042, Titled, "Development of Anti-glycan Antibodies Against Multi-drug Resistant Eskape Wound Pathogens"Defense Health Agency · USAspending ↗
$250KApr 8, 2024

Largest awards
Award	Awarded	Obligated	Ceiling
Medical R and D Purchase Order for A Dha Sttr Phase I, Proposal No. H23C-001-0042, Titled, "Development of Anti-glycan Antibodies Against Multi-drug Resistant Eskape Wound Pathogens"Defense Health Agency · USAspending ↗	Apr 8, 2024	$250K	$250K

Signed obligations on federal prime contracts (award types A–D) from USAspending, FY2008 through Oct 9, 2026. Obligations are money the government committed, not company revenue, and include de-obligations. Subcontracts and grants are excluded. Matching is by registered UEI.

Funding2 rounds · $6.0M

Equity raised: $6.0M
Latest: UndisclosedSeries A · Sep 30, 2025

Funding rounds
Announced	Stage	Amount	Valuation	Lead investors	Other investors	Confidence
Sep 30, 2025	Series A	Undisclosed	—	—	—	Speculative
Jul 26, 2021	Seed	$6.0M	—	OMX Ventures	—	Reported

Series A
Speculative
Undisclosed
Sep 30, 2025
Seed
Led by OMX Ventures
$6.0M
Jul 26, 2021

Raised counts equity rounds; debt, secondary sales and grants are totaled separately. Amounts in other currencies are converted at the announcement month's average rate. A ~ marks an estimated or converted amount.

People1

All 1 people →

Daniel Estandian
co-founder and CTO

Hiring Observations10 observed listings

View all 12 listings →

Scientist / Senior Scientist, Assay Integration (Reagents) ↗
Berkeley, CA · Other
Open when checked · Greenhouse public employer job board
Checked Oct 13, 2026
Scientist / Senior Scientist, Library Prep ↗
Berkeley, CA · Other
Open when checked · Greenhouse public employer job board
Checked Oct 13, 2026
Staff / Senior Scientist, Assay Development (Chemistry) ↗
Berkeley, CA · Other
Open when checked · Greenhouse public employer job board
Checked Oct 13, 2026
Staff / Senior Scientist, Bioconjugation Chemistry ↗
Berkeley, CA · Other
Open when checked · Greenhouse public employer job board
Checked Oct 13, 2026
(Senior) Director of Chemistry ↗
Foundry31 · Full-time · Other
Availability unverified · Black Flag job board
Checked Oct 5, 2026
Scientist, Biopolymer Chemistry ↗
Foundry31 · Full-time · Other
Availability unverified · Black Flag job board
Checked Oct 5, 2026
Scientist, Platform Development ↗
Foundry31 · Full-time · Other
Availability unverified · Black Flag job board
Checked Oct 5, 2026
Senior/Staff Scientist, Assay Development (Sample Prep) ↗
Foundry31 · Full-time · Other
Availability unverified · Black Flag job board
Checked Oct 5, 2026
Senior/Staff Scientist, Biopolymer Chemistry ↗
Foundry31 · Full-time · Other
Availability unverified · Black Flag job board
Checked Oct 5, 2026
Senior/Staff Scientist, Data Science ↗
Foundry31 · Full-time · Other
Availability unverified · Black Flag job board
Checked Oct 5, 2026

A sample of observed listings, not a total vacancy count. Availability may have changed since collection. Categories are inferred from job titles.

Sources16

Show all 16 sources and supporting evidence

Profile4

1
DatabaseGlyphic Biotechnologies - PitchBook company profile
PitchBook · Supports Organization · employee range
“employee_range: 11-50 (profile: 30)”
2
OtherGlyphic Biotechnologies - Black Flag Job Board
Black Flag · Supports Organization
“This company develops next-generation protein sequencing technology that enables highly precise, scalable, and accessible single-molecule proteome analysis to”
3
CompanyGlyphic Biotechnologies
glyphic.bio · Supports Organization · founded year
“Founded in 2021 and headquartered in Berkeley (CA), Glyphic Biotechnologies exists to fundamentally rewrite the rules of proteomics.”
4
DatabaseGlyphic Biotechnologies - LinkedIn company profile
LinkedIn · Supports Organization · employee range
“employee_range: 11-50 (profile: 11-50 employees)”

Funding2

5
DatabaseGlyphic Biotechnologies - PitchBook company profile
PitchBook · Sep 30, 2025 · Supports Funding round
“Series A”
6
NewsGlyphic Biotechnologies raises $6M to accelerate protein sequencing by orders of magnitude
TechCrunch · Jul 26, 2021 · Supports Funding round, Funding round · amount
“It was led by OMX ventures”

People1

7
NewsTenant Spotlight: Decoding the Human Proteome With Glyphic Biotechnologies - Bakar Bio Labs
bio.bakarlabs.org · Supports Role
“As a PhD candidate, Glyphic Biotechnologies co-founder and CTO Daniel Estandian was puzzled.”

Other9

8
CompanyGlyphic Biotechnologies public job board
Supports Job posting
“Scientist / Senior Scientist, Assay Integration (Reagents)”
9
OtherScientist, Biopolymer Chemistry - Glyphic Biotechnologies - Black Flag Job Board
Black Flag · Supports Job posting
“Scientist, Biopolymer Chemistry”
10
OtherScientist, Platform Development - Glyphic Biotechnologies - Black Flag Job Board
Black Flag · Supports Job posting
“Scientist, Platform Development”
11
Other(Senior) Director of Chemistry - Glyphic Biotechnologies - Black Flag Job Board
Black Flag · Supports Job posting
“(Senior) Director of Chemistry”
12
OtherSenior/Staff Scientist, Assay Development (Sample Prep) - Glyphic Biotechnologies - Black Flag Job Board
Black Flag · Supports Job posting
“Senior/Staff Scientist, Assay Development (Sample Prep)”
13
OtherSenior/Staff Scientist, Biopolymer Chemistry - Glyphic Biotechnologies - Black Flag Job Board
Black Flag · Supports Job posting
“Senior/Staff Scientist, Biopolymer Chemistry”
14
OtherSenior/Staff Scientist, Data Science - Glyphic Biotechnologies - Black Flag Job Board
Black Flag · Supports Job posting
“Senior/Staff Scientist, Data Science”
15
OtherSenior/Staff Scientist, Surface Chemistry - Glyphic Biotechnologies - Black Flag Job Board
Black Flag · Supports Job posting
“Senior/Staff Scientist, Surface Chemistry”
16
OtherVice President, Platform Development - Glyphic Biotechnologies - Black Flag Job Board
Black Flag · Supports Job posting
“Vice President, Platform Development”

Government identifiers1

UEI: F57WT7JZDH19; GLYPHIC BIOTECHNOLOGIES, INC.; Checked Oct 14, 2026

Identifiers are matched to this legal entity; related companies may hold different registrations.

Each fact on this page is attached to the sources that support it. Archived copies are linked when we keep one.